New Drugs, New Targets – Highlights from ASH22
Stephanie Lee, MD, MPH, of Fred Hutchinson Cancer Center and former president of ASH shares the key messages from a range of studies presented at the Press Briefing focused on novel therapeutic approaches and new treatment paradigms for several hematologic diseases. They all represent great expectations for better treatments and even cures, especially for patients who are heavily pre-treated and do not have a lot of other treatment options.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.